CTOs on the Move

MPI Research

www.mpiresearch.com

 
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

The Arc of Anchorage

The Arc of Anchorage is a Anchorage, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Assisted Living Locators

Assisted Living Locators is a FREE SERVICE for seniors and their families. Our experienced, compassionate team of experts is here to help you explore and understand elder care options, information, and resources...and use them to make life better for you and your loved one. You never need to worry about a `one size fits all` solution. Instead, you can rest assured that the communities and homes that we recommend have been pre-screened and personally matched to your loved one`s needs.

Orthopaedic Innovations Inc

Orthopaedic Innovations Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

Dedicated Clinical Research II-IV

Dedicated Clinical Research II-IV is a Litchfield Park, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.